Randomized, Double-Blind, Placebo-Controlled Study of Supplemental Oral L-Arginine in Patients with Heart Failure

Circulation

Volumn 93, Issue 12, 1996, Pages 2135-2141

  Rector, Thomas S ^a   Bank, Alan J ^a   Mullen, Kathleen A ^a   Tschumperlin, Linda K ^a   Sih, Ronald ^a   Pillai, Kamalesh ^a   Kubo, Spencer H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Endothelium; Heart failure; L arginine

Indexed keywords

ACETYLSALICYLIC ACID; ARGININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENDOTHELIN; METHACHOLINE; N(G) METHYLARGININE; NITRIC ACID DERIVATIVE; NITROPRUSSIDE SODIUM;

ADULT; AGED; ARM EXERCISE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOREARM BLOOD FLOW; HEALTH STATUS; HEART FAILURE; HUMAN; HYPEREMIA; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ARGININE; CARDIAC OUTPUT, LOW; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERTION; FEMALE; FOREARM; HUMANS; MALE; MIDDLE AGED; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; QUALITY OF LIFE; REGIONAL BLOOD FLOW; VASOCONSTRICTION;

EID: 0029993977     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.12.2135     Document Type: Article

References (46)

1. Leithe ME, Margorien RD, Hermiller JB, Unverferth DV, Leier CV. Relationships between central hemodynamics and regional blood flow in normal subjects and in patients with congestive heart failure. Circulation. 1984;69:57-64.
2. Zelis R, Longhurst J, Capone RJ, Mason DT. A comparison of regional blood flow and oxygen utilization during dynamic forearm exercise in normal subjects and patients with congestive heart failure. Circulation. 1974;50:137-143.
3. Sullivan MJ, Knight JD, Higginbotham MB, Cobb FR. Relation between central and peripheral hemodynamics during exercise in patients with chronic heart failure: muscle blood flow is reduced with maintenance of arterial perfusion pressure. Circulation. 1989; 80:769-781.
4. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 1991;84:1589-1596.
5. Nakamura M, Ishikawa M, Funakoshi T, Hashimoto K, Chiba M, Hiramori K. Attenuated endothelium-dependent peripheral vasodilation and clinical characteristics in patients with chronic heart failure. Am Heart J. 1994;128:1164-1169.
6. Katz SD, Biasucci L, Sabba C, Strom JA, Jondeau G, Galvao M, Solomon S, Nikolic SD, Forman R, LeJemtel TH. Impaired endothelium-mediated vasodilatation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 1992;19: 918-925.
7. Drexler H, Hayoz D, Munzel T, Hornig B, Just H, Brunner HR, Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992;69:1596-1601.
8. Mancini DM, Davis L, Wexler JP, Chadwick B, LeJemtel TH. Dependence of enhanced maximal exercise performance on increased peak skeletal muscle perfusion during long-term captopril therapy in heart failure. J Am Coll Cardiol. 1987;10:845-850.
9. Palmer RMJ, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
10. Castillo L, DeRojas TC, Chapman TE, Vogt J, Burke JF, Tannenbaum SR, Young VR. Splanchnic metabolism of dietary arginine in relation to nitric oxide synthesis in normal adult man. Proc Natl Acad Sci U S A. 1993;90:193-197.
11. Arnal JF, Munzel T, Venema RC, James NL, Bai C, Mitch WE, Harrison DG. Interactions between L-arginine and L-glutamine change endothelial NO production. J Clin Invest. 1995;95: 2565-2572.
12. Gold ME, Bush PA, Ignarro LJ. Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. Biochem Biophys Res Commun. 1989;164:714-721.
13. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP. L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J Clin Invest. 1992;90: 1248-1253.
14. Drexler H, Fischell TA, Pinto FJ, Chenzbraun A, Botas J, Cooke JP, Alderman EL. Effect of L-argimne on coronary endothelial function in cardiac transplant recipients. Circulation. 1994;89: 1615-1623.
15. Hirooka Y, Imaizumi T, Tagawa T, Shiramoto M, Endo T, Ando S, Takeshita A. Effects of L-arginine on impaired acetylcholine-induced and ischemic vasodilation of the forearm in patients with heart failure. Circulation. 1994;90:658-668.
16. Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:1168-1172.
17. Rector TS, Cohn JN. Assessment of patient outcome with the Minnesota Living With Heart Failure questionnaire: reliability and validity during a randomized, double-blind placebo-controlled trial of pimobendan. Am Heart J. 1992;124:1017-1025.
18. Rector TS, Kubo SH, Cohn JN. Validity of the Minnesota Living With Heart Failure questionnaire as a measure of therapeutic response to enalapril or placebo. Am J Cardiol. 1993;71:1106-1107.
19. Lipkin DP, Scriven AJ, Crake T, Poole-Wilson PA. Six minute walking test for assessing exercise capacity in chronic heart failure. Br Med J. 1986;292:653-655.
20. Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, Kronenberg MW, Kostis JB, Kohn RM, Guillotte M, Greenberg B, Woods PA, Bourassa MG. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA. 1993;270:1702-1707.
21. Arnold JMO, Rebeiro JP, Colucci WS. Muscle blood flow during forearm exercise in patients with severe heart failure. Circulation. 1990;82:465-472.
22. Bank AJ, Wilson RF, Kubo SH, Holte JE, Dresing TJ, Wang H. Direct effects of smooth muscle relaxation and contraction on in vivo human brachial artery elastic properties. Circ Res. 1995;77: 1008-1016.
23. Cohn JN, Finkelstein S, McVeigh G, Morgan D, LeMay L, Robinson J, Mock J. Noninvasive pulse wave analysis for the early detection of vascular disease. Hypertension. 1995;26:503-508.
24. Watt TB, Burrus C. Arterial pressure contour analysis for estimating human vascular properties. J Appl Physiol. 1976;40:171-176.
25. Zanzinger J, Czachurski J, Seller H. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res. 1994;75:1073-1077.
26. Saijonmaa O, Ristimaki A, Fyhrquist F. Atrial natriuretic peptide, nitroglycerine and nitroprusside reduce basal and stimulated endothelin production from cultured endothelial cells. Biochem Biophys Res Commun 1990;173:514-520.
27. Boulanger C, Luscher TF. Release of endothelin from the porcine aorta inhibition by endothelium-derived nitric oxide. J Clin Invest. 1990;95:587-590.
28. Lerman A, Hildebrand FL, Aarhus LL, Burnett JC. Endothelin has biological actions at pathophysiological concentrations. Circulation. 1991;83:1808-1814.
29. Candito M, Krstulovic C, Sbirazzuoli V, Chambon P. Proposal for the standardizauon of the calibration method for the assay of plasma catecholamines. J Chromatogr. 1990;526:194-202.
30. Barbul A. Arginine: biochemistiy, physiology and therapeutic implications. J Parent Enteral Nutr. 1986;10:227-238.
31. Mayhan WG, Rubinstein I. Acetylcholine induces vasoconstriction in the microcirculation of cardiomyopathic hamsters: reversal by L-arginine. Biochem Biophys Res Commun. 1992;184:1372-1377.
32. Gilligan DM, Panza JA, Kilcoyne CM, Waclawiw MA, Casino PR, Quyyumi AA. Contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation. 1994;90:2853-2858.
33. Tagawa J, Imaizumi T, Endo T, Shiramoto M, Harasawa Y, Takeshita A. Role of nitric oxide in reactive hyperemia in human forearm vessels. Circulation. 1994;90:2285-2290.
34. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cell in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980;288:373-376.
35. Finkelstein SM, Cohn JN, Collins VR, Carlyle PF, Shelley WJ. Vascular hemodynamic impedance in congestive heart failure. Am J Cardiol. 1985;55:423-427.
36. Arnold JMO, Marchiori GE, Imrie JR, Burton GL, Pflugfelder PW, Kostuk WJ. Large artery function in patients with chrome heart failure. Circulation. 1991;84:2418-2425.
37. Lage SG, Kopel L, Monachini MC, Medeiros CJ, Pileggi F, Polak JF, Creager MA. Carotid arterial compliance in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy. Am J Cardiol. 1994;74:691-695.
38. Vita JA, Treasure CB, Yeung AC, Vekshtein VI, Fantasia GM, Fish RD, Ganz P, Selwyn AP. Patients with evidence of coronary endothelial dysfunction as assessed by acetylcholine infusion demonstrate marked increase in sensitivity to constrictor effects of catecholamines. Circulation. 1992;85:1390-1397.
39. Gaballa MA, Raya TE, Goldman S. Large artery remodeling after myocardial infarction. Am J Physiol. 1995;37:H2092-H3103.
40. Schieffer B, Wollert KC, Berchtold M, Sall K, Schieffer E, Hornig B, Riede UN, Drexler H. Development and prevention of skeletal muscle structural alterations after experimental myocardial infarction. Am J Physiol. 1995;38:H1507-H1513.
41. Hamon M, Vallet B, Bauters C, Wernert N, McFadden EP, Lablanche JM, Dupuis B, Bertrand ME. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation. 1994;90:1357-13662.
42. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotripic response to β-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 1995;92:2198-2203.
43. Kiowski W, Sutsch G, Hunziker P, Muller P, Kim J, Oechslin E, Schmitt R, Jones R, Bertel O. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 1995:346: 732-736.
44. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546-1550.
45. Stroes ESG, Koomans HA, de Bruin TWA, Rabelink TJ. Vascular funtion in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication. Lancet. 1995;346:467-471.
46. Adams MR, Forsyth CJ, Jessup W, Robinson J, Celermajer DS. Oral L-arginine inhibits platelet aggregation but does no enhance endothelium-dependent dilation in healthy young men. J Am Coll Cardiol. 1995;26:1054-1061.